Comment from Mayo Clinic

Summary: Dr. Lorraine A. Fitzpatrick, a Professor of Medicine and Director of the Women’s Health Fellowship, opposes the FDA's withdrawal of estrogen-androgen combination drugs. She argues that these medications are essential for treating vasomotor symptoms and improving quality of life for a large population of postmenopausal women.